Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

Company Profiles Market

Company Profiles News

Company Profiles Stocks

Company Profiles Market
Company Profiles News
Company Profiles Stocks

Eli Lilly and Company

NYSE:LLY:US

Featured Articles and Interviews

Apr 08, 2025

Top 5 Small-cap Pharma Stocks in 2025

Feb 25, 2025

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Jan 22, 2025

Biotech Market Forecast: Top Trends for Biotech in 2025

More Featured Articles and Inverviews

Press Releases

Jun 05, 2024

Lilly announces departure of Anat Ashkenazi, chief financial officer

Jun 04, 2024

Melissa Seymour to join Lilly as executive vice president of Global Quality

Jun 01, 2024

Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting

More Press Releases

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Go Deeper

AI Powered

Senior woman doing exercises alongside closeup of DNA.

5 US Longevity and Anti-aging Stocks to Watch in 2025

Row of test tubes and pipette with chemical droplet chemical coming from it.

Top 5 Small-cap Biotech Stocks of 2025

Interactive Chart

Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.